Oncternal Therapeutics Inc (ONCT)

US68236P2065 - Common Stock

0.5266  -0.17 (-24.11%)

After market: 0.61 +0.08 (+15.84%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to ONCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.04. This target is 287.39% above the current price.
ONCT was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ONCT.
In the last month the buy percentage fell by 37 points. So the trust of analysts is decreasing.
ONCT was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.532.022.042.042.10 - 283.59% 287.39% 287.39% 298.78%
Up and Down Grades
Date Firm Action Rating
2024-09-12 Brookline Capital Downgrade Buy -> Hold
2024-09-12 Northland Capital Markets Downgrade Outperform -> Market Perform
2024-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-01-29 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-04 Brookline Capital Upgrade Hold -> Buy
2023-09-18 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-09-07 Cantor Fitzgerald Reiterate Neutral -> Neutral
2023-06-06 HC Wainwright & Co. Reiterate Neutral
2023-04-04 Cantor Fitzgerald Maintains Overweight
2023-04-04 Brookline Capital Downgrade Buy -> Hold
2023-04-04 Oppenheimer Downgrade Outperform -> Perform
2023-04-04 Maxim Group Downgrade Buy -> Hold
2023-04-04 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-03-22 Oppenheimer Maintains Outperform
2023-03-14 HC Wainwright & Co. Reiterate Buy
2022-12-22 Cantor Fitzgerald Initiate Overweight
2022-08-10 HC Wainwright & Co. Maintains Buy
2022-05-10 Maxim Group Initiate Buy
2022-02-24 BTIG Initiate Buy
2021-04-07 Oppenheimer Initiate Outperform
2021-03-30 Brookline Capital Initiate Buy
2021-03-12 HC Wainwright & Co. Maintains Buy